Healthcare >> CEO Interviews >> January 27, 2003
STEPHEN BENOIT is co-Founder, President and Chief Executive
Officer of NanoMed Pharmaceuticals, Inc., an early stage advanced
drug delivery company. Mr. Benoit has uniquely broad industry
experience gained over 20 years in the consumer packaged goods,
biotechnology, disease management, pharmaceuticals, and financial
services industries. Having been successful in startup, as well
as Fortune 250 environments, his background includes general
management, mergers and acquisitions, strategic planning, product
development, international operations management and business
development, and corporate finance. Prior to co-founding NanoMed,
Mr. Benoit was a corporate officer and member of the USA
Executive Management Committee of Kellogg Company, responsible
for Kellogg's natural and functional foods division. Previously,
he served as Vice President, Marketing and Sales, AMBI, Inc, a
food and pharmaceutical company, and Vice President, Marketing,
Calgene Fresh, Inc., a subsidiary of a leading biotechnology
company. Mr. Benoit began his career at Bank of America. Mr.
Benoit received his MBA in Finance from Loyola Marymount
University and is a member of Alpha Sigma Nu, the national Jesuit
academic honor society. He has completed executive education
programs at Harvard University's John F. Kennedy School of
Government and the Harvard Business School. Profile
TWST: Would you give us a brief history of NanoMedPharmaceuticals as well as an overview of what you do?
Mr. Benoit: NanoMed Pharmaceuticals is an early-stage advanced
drug delivery company